Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury
Related Experiment Video
Updated: Jan 29, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Anna Krzywonos-Zawadzka1, Aleksandra Franczak1, Agnieszka Olejnik1
1Department of Medical Laboratory Diagnostics, Division of Clinical Chemistry, Wroclaw Medical University, Wroclaw, Poland.
Abstract:
Hypoxic injury of cardiovascular system is one of the most frequent complications following ischaemia. Heart injury arises from increased degradation of contractile proteins, such as myosin light chains (MLCs) and troponin I by matrix metalloproteinase 2 (MMP-2). The aim of the current research was to study the effects of 5-phenyloxyphenyl-5-aminoalkyl nitrate barbiturate (MMP-2-inhibitor-NO-donor hybrid) on hearts subjected to ischaemia/reperfusion (I/R) injury. Primary human cardiac myocytes and Wistar rat hearts perfused using Langendorff method have been used. Human cardiomyocytes or rat hearts were subjected to I/R in the presence or absence of tested hybrid. Haemodynamic parameters of heart function, markers of I/R injury, gene and protein expression of MMP-2, MMP-9, inducible form of NOS (iNOS), asymmetric dimethylarginine (ADMA), as well as MMP-2 activity were measured. Mechanical heart function, coronary flow (CF) and heart rate (HR) were decreased in hearts subjected to I/R Treatment of hearts with the hybrid (1-10 µmol/L) resulted in a concentration-dependent recovery of mechanical function, improved CF and HR. This improvement was associated with decreased tissue injury and reduction of synthesis and activity of MMP-2. Decreased activity of intracellular MMP-2 led to reduced degradation of MLC and improved myocyte contractility in a concentration-dependent manner. An infusion of a MMP-2-inhibitor-NO-donor hybrid into I/R hearts decreased the expression of iNOS and reduced the levels of ADMA. Thus, 5-phenyloxyphenyl-5-aminoalkyl nitrate barbiturate protects heart from I/R injury.
Insights
A novel hybrid compound protects the heart from ischemia/reperfusion injury by inhibiting matrix metalloproteinase 2 (MMP-2). This reduces contractile protein degradation, improving heart function and reducing tissue damage.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Biochemistry
Background:
- Ischaemia/reperfusion (I/R) injury is a major cause of cardiovascular complications.
- Matrix metalloproteinase 2 (MMP-2) degrades contractile proteins, contributing to heart injury during I/R.
- Novel therapeutic strategies are needed to mitigate I/R-induced cardiac damage.
Purpose of the Study:
- To investigate the protective effects of a novel MMP-2-inhibitor-NO-donor hybrid (5-phenyloxyphenyl-5-aminoalkyl nitrate barbiturate) against I/R injury in cardiac myocytes and rat hearts.
- To assess the compound's impact on cardiac function, MMP-2 activity, and related molecular markers.
Main Methods:
- Primary human cardiac myocytes and Wistar rat hearts were subjected to I/R.
- The novel hybrid compound was administered in varying concentrations.
- Evaluated hemodynamic parameters, tissue injury markers, MMP-2 activity, and expression of MMP-2, MMP-9, iNOS, and ADMA.
Main Results:
- I/R significantly impaired heart function, reducing mechanical performance, coronary flow (CF), and heart rate (HR).
- The hybrid compound dose-dependently restored mechanical function, CF, and HR.
- Treatment reduced tissue injury, MMP-2 synthesis and activity, leading to decreased degradation of myosin light chains (MLCs) and improved myocyte contractility.
- The hybrid also decreased inducible nitric oxide synthase (iNOS) expression and asymmetric dimethylarginine (ADMA) levels.
Conclusions:
- 5-phenyloxyphenyl-5-aminoalkyl nitrate barbiturate demonstrates significant cardioprotective effects against I/R injury.
- The compound's mechanism involves MMP-2 inhibition, preserving contractile proteins and improving cardiac function.
- This novel hybrid represents a promising therapeutic agent for managing I/R-induced heart damage.
Related Concept Videos
Hybridization of Atomic Orbitals I
Hybridization of Atomic Orbitals II
Hybrid Zones
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
In-situ Hybridization
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...

